Company intelligence / Profile preview

Excel Diagnostics and Nuclear Oncology Center

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

Excel Diagnostics and Nuclear Oncology Center is a leading imaging and nuclear therapy facility, designated as a Radiopharmaceutical Therapy Center of Excellence, conducting clinical trials on innovative radiopharmaceuticals such as 225Ac-PSMA I&T for metastatic castration-resistant prostate cancer, with recent FDA IND authorization for this therapy[1][2].

Therapeutic areas: OncologyEndocrinology
Modalities: RadiopharmaceuticalRadioligand therapyDiagnostic imaging
Industry: Academic Hospital/University/Research

Partnerships

Society of Nuclear Medicine and Molecular Imaging (SNMMI) (designation as Center of Excellence)[1][2]

Beyond the preview

Go deeper on Excel Diagnostics and Nuclear Oncology Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Excel Diagnostics and Nuclear Oncology Center.

Explore the full profile